ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 259 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $812,000 | -95.9% | 8,732 | -96.9% | 0.00% | -96.2% |
Q1 2021 | $19,784,000 | -44.7% | 285,115 | -38.8% | 0.03% | -49.0% |
Q4 2020 | $35,765,000 | +1901.4% | 465,510 | +1847.7% | 0.05% | +1600.0% |
Q3 2020 | $1,787,000 | -74.7% | 23,900 | -84.6% | 0.00% | -81.2% |
Q4 2019 | $7,069,000 | +49.1% | 155,628 | +92.4% | 0.02% | +45.5% |
Q2 2019 | $4,741,000 | +984.9% | 80,871 | +631.4% | 0.01% | +1000.0% |
Q1 2018 | $437,000 | – | 11,057 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 252,500 | $11,320,000 | 4.95% |
Rubric Capital Management LP | 857,103 | $38,424,000 | 3.59% |
PFM Health Sciences, LP | 3,255,230 | $145,932,000 | 3.22% |
Partner Investment Management, L.P. | 40,605 | $1,820,000 | 2.10% |
DAFNA Capital Management LLC | 93,942 | $4,211,000 | 1.82% |
Atika Capital Management LLC | 195,000 | $8,742,000 | 1.78% |
Perceptive Advisors | 1,400,171 | $62,770,000 | 1.77% |
EMORY UNIVERSITY | 47,779 | $2,142,000 | 1.51% |
Rhenman & Partners Asset Management AB | 234,558 | $10,515,000 | 1.23% |
Eversept Partners, LP | 75,721 | $3,394,572 | 0.99% |